EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word: Development of Sales/Annual Results
SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at.
The SDax newcomer Schott Pharma earned more in the past financial year despite customers reducing their inventories. The Mainz-based company said on Tuesday that it benefited above all from the.
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Development of Sales/Annual ResultsSCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance 19.12.2023 / 09:30 CET/CESTThe issuer is solely responsible for the content of this announcement.SCHOTT Phar.